Withaferin A |
Not Available |
Inhibited SARS-CoV-2 Mpro, thus preventing SARS-CoV-2 replication |
[90] |
|
Not Available |
Inhibited SARS-CoV-2 Mpro and structural proteins, including S, E, and N, thus impeding viral replication and entry into host cells |
[93] |
|
Purchased from Sigma-Aldrich (now Merck, St. Louis, MO, USA) |
Inhibited SARS-CoV-2 Mpro, thus disrupting SARS-CoV-2 replication |
[94] |
|
Not Available |
Inhibited TMPRSS2 receptor, thereby preventing viral entry into host cells |
[95] |
|
Not Available |
Inhibited SARS-CoV-2 Mpro and GRP78, thus impeding viral replication and SARS-CoV-2 recognition by host cells |
[96] |
Withanolide A |
Leaves, stems, roots, and flowers extract |
Inhibited SARS-CoV and SARS-CoV-2 S protein, SARS-CoV 3CL-pro main protease, and SARS-CoV-2 NSP10/NSP-16 complex, thus decreasing viral recognition and replication in host cells |
[97] |
Withanolide B |
Not Available |
Inhibited SARS-CoV-2 Mpro and structural proteins, including S, E, and N. |
[93] |
Withanolide R |
Not Available |
Inhibited main protease (NSP5) of SARS-CoV-2, consequently reducing the survival of SARS-CoV-2 |
[98] |
2,3-Dihydrowithaferin A |
Not Available |
Inhibited SARS-CoV-2 S protein and acted as the most potent S protein inhibitor as compared with the other WS phytochemicals, preventing viral entry into host cells |
[98] |
Withanone |
Not Available |
Inhibited TMPRSS2 receptor and downregulated TMPRSS2 mRNA, thereby impeding SARS-CoV-2 entry into host cells |
[95] |
Not Available |
Inhibited SARS-CoV-2 main protease 3CL-pro and S protein, thus decreasing viral entry and replication in host cells |
[99] |
Leaves and stem extract |
Inhibited SARS-CoV-2 TMPRSS2 and Mpro, thus prohibiting SARS-CoV-2 entry and replication in host cells |
[100] |
Not Available |
Inhibited SARS-CoV-2 Mpro, thus halting SARS-CoV-2 replication in host cells |
[101] |
Root extract |
Inhibited viral entry by attenuating the interaction between the host ACE2 receptor and RBD located in the SARS-CoV-2 S-protein |
[102] |
Purchased from Sigma-Aldrich (now Merck, St. Louis, MO, USA) (>98% purity) |
Inhibited SARS-CoV-2 Mpro, thus disrupting SARS-CoV-2 replication |
[94] |
Withanoside IV |
Root extract |
Abrogated NSP10-NSP16 switching mechanisms in SARS-CoV-2, thus promoting fatality of SARS-CoV-2 |
[103] |
Withanoside V |
Not Available |
Inhibited SARS-CoV-2 Mpro, thus attenuating SARS-CoV-2 replication in host cell |
[104] |
Not Available |
Inhibited SARS-CoV-2 Mpro, thus attenuating SARS-CoV-2 replication in host cells |
[105] |
Withanoside X |
Not Available |
Inhibited SARS-CoV-2 NSP15 endoribonuclease and SARS-CoV-2 S protein, thus preventing SARS-CoV-2 entry and replications in host cells |
[106] |
Quercetin glucoside |
Not Available |
Inhibited SARS-CoV-2 NSP15 endoribonuclease and SARS-CoV-2 S proteins, thus reducing SARS-CoV-2 entry and replication in host cells |
[106] |
Somniferin |
Not Available |
Inhibited SARS-CoV-2 Mpro, thus attenuating SARS-CoV-2 replication in host cells |
[104] |